Evidence map›Paper›PMID 33669829›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Evaluation of MicroScan Bacterial Identification Panels for Low-Resource Settings.

Sien Ombelet, Alessandra Natale, Jean-Baptiste Ronat, Olivier Vandenberg, Liselotte Hardy, Jan Jacobs

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Validation of Three MicroScanDiagnostics (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Identification and Characterization of a NewFrontiers in microbiology · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sien OmbeletDepartment of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.ORCID 0000-0002-4943-0736
Alessandra NataleMédecins Sans Frontières, Operational Center Paris, 75019 Paris, France.
Jean-Baptiste RonatMédecins Sans Frontières, Operational Center Paris, 75019 Paris, France.
Olivier VandenbergCenter for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.ORCID 0000-0003-0484-4502
Liselotte HardyDepartment of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Jan JacobsDepartment of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.ORCID 0000-0002-8657-6777

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial identification is challenging in low-resource settings (LRS). We evaluated the MicroScan identification panels (Beckman Coulter, Brea, CA, USA) as part of Médecins Sans Frontières' Mini-lab Project. The MicroScan Dried Overnight Positive ID Type 3 (PID3) panels for Gram-positive organisms and Dried Overnight Negative ID Type 2 (NID2) panels for Gram-negative organisms were assessed with 367 clinical isolates from LRS. Robustness was studied by inoculating Gram-negative species on the Gram-positive panel and vice versa. The ease of use of the panels and readability of the instructions for use (IFU) were evaluated. Of species represented in the MicroScan database, 94.6% (185/195) of Gram-negative and 85.9% (110/128) of Gram-positive isolates were correctly identified up to species level. Of species not represented in the database (e.g.,

Indexed as

bacterial identificationblood culturesclinical bacteriologylow-resource settingsMicroScan identification system

Identifiers

PMID33669829
PMCPMC7922174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.